Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records

Yan Xie, Benjamin Bowe, Hong Xian, Travis Loux, Janet B. McGill, Ziyad Al‐Aly

The Lancet Diabetes & Endocrinology · 2023 · 92 citations · 59 references

Concepts

References

59